Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 1996 AL 2010

Hypometabolism, Alzheimer's Disease, and Possible Therapeutic Targets: An Overview

Raut S, Bhalerao A, Powers M, Gonzalez M, Mancuso S, Cucullo L.

Cells. 2023 Aug 8;12(16):2019. doi: 10.3390/cells12162019.

The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain

Maran JJ, Adesina MM, Green CR, Kwakowsky A, Mugisho OO.

Ageing Res Rev. 2023 Jul;88:101954. doi: 10.1016/j.arr.2023.101954. Epub 2023 May 13.

Effect of arctigenin on neurological diseases: A review

Li M, Jiang H, Wang Y, Xu Z, Xu H, Chen Y, Zhu J, Lin Z, Zhang M.

J Ethnopharmacol. 2023 Oct 28;315:116642. doi: 10.1016/j.jep.2023.116642. Epub 2023 May 24.

Deep brain stimulation of fornix in Alzheimer's disease: From basic research to clinical practice

Liu Z, Shu K, Geng Y, Cai C, Kang H.

Eur J Clin Invest. 2023 Aug;53(8):e13995. doi: 10.1111/eci.13995. Epub 2023 Apr 10.

Applications of Artificial Intelligence to Diagnosis of Neurodegenerative Diseases

Feng T.

Stud Health Technol Inform. 2023 Nov 23;308:648-655. doi: 10.3233/SHTI230896.

Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease

Li L, Zhang J, Huang X, Du J, Tu Z, Wu H, Liu X, Yuan M.

Curr Pharm Des. 2023;29(2):95-115. doi: 10.2174/1381612829666221216114912.

Monoclonal antibodies for the management of central nervous system diseases: clinical success and future strategies

Singh Gautam A, Pandey SK, Lasure V, Dubey S, Singh RK.

Expert Opin Biol Ther. 2023 Jul-Dec;23(7):603-618. doi: 10.1080/14712598.2023.2227378. Epub 2023 Jun 27.

Race and Ethnicity in Lewy Body Dementia: A Narrative Review

Bayram E, Holden SK, Fullard M, Armstrong MJ; Lewy Body Dementia Association Community Engagement Working Group.

J Alzheimers Dis. 2023;94(3):861-878. doi: 10.3233/JAD-230207.

A case of exploding head syndrome preceding the onset of mild cognitive impairment with Lewy bodies

Kitagawa S, Okamoto N, Ikenouchi A, Igata R, Hashimoto R, Konishi Y, Tesen H, Yoshimura R.

Psychogeriatrics. 2023 Mar;23(2):368-370. doi: 10.1111/psyg.12938. Epub 2023 Jan 27.

Advances in Diagnosis and Prognosis of Parkinson Disease: Value of CSF Proteomics

Parnetti L, Bellomo G.

Neurology. 2023 Oct 3;101(14):595-596. doi: 10.1212/WNL.0000000000207724. Epub 2023 Aug 16.

Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer's Disease

Yang Y, Bagyinszky E, An SSA.

Int J Mol Sci. 2023 May 8;24(9):8417. doi: 10.3390/ijms24098417.

Neurodevelopmental toxicity induced by PM2.5 Exposure and its possible role in Neurodegenerative and mental disorders

Liu XQ, Huang J, Song C, Zhang TL, Liu YP, Yu L.

Hum Exp Toxicol. 2023 Jan-Dec;42:9603271231191436. doi: 10.1177/09603271231191436.

Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort

Nudelman KNH, Jackson T, Rumbaugh M, Eloyan A, Abreu M, Dage JL, Snoddy C, Faber KM, Foroud T, Hammers DB; DIAN/DIAN-TU Clinical/Genetics Committee; Taurone A, Thangarajah M, Aisen P, Beckett L, Kramer J, Koeppe R, Kukull WA, Murray ME, Toga AW, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu JC, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG; LEADS Consortium.

Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S64-S73. doi: 10.1002/alz.13482. Epub 2023 Oct 6.

Metal-Organic Frameworks as Sensors for Human Amyloid Diseases

Leite JP, Figueira F, Mendes RF, Almeida Paz FA, Gales L.

ACS Sens. 2023 Mar 24;8(3):1033-1053. doi: 10.1021/acssensors.2c02741. Epub 2023 Mar 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias